Antibe Therapeutics (ATE) Stock Chart & Stock Price History → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free ATE Stock Alerts C$0.30 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades Antibe Therapeutics Stock Price Performance5 Day PerformanceN/A1 Month PerformanceN/A3 Month Performance-67.93%6 Month Performance-58.45%Year-To-Date Performance-68.28%1 Year Performance-41.00% Receive ATE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Chaikin AnalyticsWall Street legend who predicted 2021 tech crash issues new warningPeople around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge ATE Stock Chart for Wednesday, May, 15, 2024 ATE Chart by TradingView Antibe Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/10/2024C$0.30C$0.30C$0.35C$0.26167,044 shsC$15.54 million04/09/2024C$0.30C$0.30C$0.35C$0.26167,044 shsC$15.54 million04/08/2024C$0.26C$0.30+13.46%C$0.35C$0.26167,044 shsC$15.54 million04/05/2024C$0.30C$0.26-11.86%C$0.30C$0.25137,518 shsC$13.69 million04/04/2024C$0.27C$0.30+11.32%C$0.34C$0.26160,906 shsC$15.54 million04/03/2024C$0.19C$0.27+43.24%C$0.30C$0.20469,101 shsC$13.96 million Get the Latest News and Ratings for ATE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/02/2024C$0.17C$0.19+12.12%C$0.19C$0.17721,169 shsC$9.74 million04/01/2024C$0.45C$0.17-63.33%C$0.24C$0.151.63 million shsC$8.69 million03/29/2024C$0.45C$0.45C$0.47C$0.4351,300 shsC$23.70 million03/28/2024C$0.43C$0.45+4.65%C$0.47C$0.4351,300 shsC$23.70 million03/27/2024C$0.44C$0.43-1.15%C$0.44C$0.437,128 shsC$22.65 million03/26/2024C$0.43C$0.44+1.16%C$0.44C$0.4323,174 shsC$22.91 million03/25/2024C$0.43C$0.43+1.18%C$0.44C$0.436,415 shsC$22.65 million03/22/2024C$0.43C$0.43C$0.47C$0.4267,444 shsC$22.39 million03/21/2024C$0.41C$0.43+4.94%C$0.43C$0.4141,445 shsC$22.39 million03/20/2024C$0.41C$0.41C$0.43C$0.4076,235 shsC$21.33 million03/19/2024C$0.43C$0.41-4.71%C$0.44C$0.40126,214 shsC$21.33 million03/18/2024C$0.43C$0.43-1.16%C$0.44C$0.4316,000 shsC$22.39 million03/15/2024C$0.46C$0.43-5.49%C$0.45C$0.4364,000 shsC$22.65 million03/14/2024C$0.48C$0.46-4.21%C$0.49C$0.4467,065 shsC$23.97 million03/13/2024C$0.46C$0.48+3.26%C$0.49C$0.44106,943 shsC$25.02 million03/12/2024C$0.43C$0.46+8.24%C$0.47C$0.4544,233 shsC$24.23 million03/11/2024C$0.45C$0.43-5.56%C$0.47C$0.4388,421 shsC$22.39 million03/08/2024C$0.52C$0.45-13.46%C$0.53C$0.45251,210 shsC$23.70 million03/07/2024C$0.51C$0.52+1.96%C$0.56C$0.50178,477 shsC$27.39 million03/06/2024C$0.53C$0.51-3.77%C$0.61C$0.40571,296 shsC$26.86 million03/05/2024C$0.50C$0.53+6.00%C$0.56C$0.51245,570 shsC$27.92 million03/04/2024C$0.97C$0.50-48.45%C$0.59C$0.301.63 million shsC$26.34 million03/01/2024C$0.96C$0.97+1.04%C$1.02C$0.9758,951 shsC$51.09 million02/29/2024C$0.97C$0.96-1.03%C$0.99C$0.9572,122 shsC$50.56 million02/28/2024C$0.99C$0.97-2.02%C$0.99C$0.9650,683 shsC$51.09 million02/27/2024C$1.01C$0.99-1.98%C$1.03C$0.9981,747 shsC$52.14 million02/26/2024C$1.03C$1.01-1.94%C$1.05C$1.0143,248 shsC$53.20 million02/23/2024C$0.98C$1.03+5.10%C$1.08C$0.95174,626 shsC$54.25 million02/22/2024C$0.96C$0.98+2.08%C$0.99C$0.9770,600 shsC$51.62 million02/21/2024C$0.95C$0.96+1.05%C$0.97C$0.9519,500 shsC$50.56 million02/20/2024C$0.93C$0.95+2.15%C$0.99C$0.9463,511 shsC$50.04 million02/19/2024C$0.93C$0.93C$0.97C$0.9039,730 shsC$48.96 million02/16/2024C$0.92C$0.93+1.09%C$0.97C$0.9039,731 shsC$48.96 million02/15/2024C$0.90C$0.92+2.22%C$0.94C$0.8885,698 shsC$48.43 millionWall Street legend who predicted 2021 tech crash issues new warning (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch his stock warning right here, 100% free of charge02/14/2024C$0.89C$0.90+1.12%C$0.91C$0.8838,225 shsC$47.38 million Related Companies: Resverlogix Stock Price Chart Kane Biotech Stock Price Chart Sirona Biochem Stock Price Chart Ceapro Stock Price Chart Covalon Technologies Stock Price Chart Innovotech Stock Price Chart Aptose Biosciences Stock Price Chart Quest PharmaTech Stock Price Chart IBEX Technologies Stock Price Chart Devonian Health Group Stock Price Chart Receive ATE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:ATE) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings"The Biggest Drug Ever" Is ComingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Antibe Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
